Login

Financial Snapshot

Revenue
TTM
$551.3M
Gross Margin
TTM
78.1%
Net Income
TTM
-$189.3M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
543.26%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
670.9M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$35.09M

Stock Price

Loading...
Market Cap: $6.5065 Billion

About Glaukos Corp

Glaukos Corporation (NYSE: GKOS) is a ophthalmic medical device company that develops and commercializes surgical and pharmaceutical products targeting glaucoma and corneal health conditions. The company generates revenue primarily through the sale of its micro-invasive glaucoma surgery (MIGS) devices and corneal health products to hospitals, ambulatory surgery centers, and eye care professionals. The 10-K filed 2026-02-23 (accession 000119312526061944) covers the fiscal year ended in that cycle, but the filing excerpts provided contain only the cover page and do not disclose segment revenue breakdowns, customer concentration figures, geographic mix, or named competitors. Based solely on the available filing content, Glaukos is incorporated and operates as a publicly traded U.S. medical device company listed on a national exchange under the ticker GKOS, focused on ophthalmic conditions.

Revenue model
The filing excerpts provided do not contain sufficient detail to describe the revenue model beyond that Glaukos sells ophthalmic medical devices and related products. No pricing model, segment percentages, or unit economics are disclosed in the available excerpts.
Products and services
The filing excerpts do not enumerate specific products or brands beyond the company's general focus on glaucoma and corneal health surgical devices.
Customers and end markets
The filing excerpts do not identify specific customers, customer concentration figures, or end market details.
Value-chain role
Medical device manufacturer and seller in the ophthalmic surgery supply chain, based on the company's general description in the filing.
Geographic exposure
The filing excerpts do not disclose geographic revenue breakdown or operational footprint details.

Source: SEC 10-K, filed 2026-02-23

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories AtriCure Inc Axonics, Inc. Enovis Corp Conmed Corp Integer Holdings Corp Integra Lifesciences Holdings Corp NUVASIVE INC Procept Biorobotics Corp Tandem Diabetes Care Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support